Cargando…
Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study
The prognosis of steroid-refractory acute graft-versus-host disease (aGVHD) remains poor and better treatments are urgently needed. Multipotent mesenchymal stromal cell (MSC)-based therapy emerged as a promising approach but response rates were highly variable across studies. We conducted a multicen...
Autores principales: | Servais, Sophie, Baron, Frédéric, Lechanteur, Chantal, Seidel, Laurence, Selleslag, Dominik, Maertens, Johan, Baudoux, Etienne, Zachee, Pierre, Van Gelder, Michel, Noens, Lucien, Kerre, Tessa, Lewalle, Philippe, Schroyens, Wilfried, Ory, Aurélie, Beguin, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945536/ https://www.ncbi.nlm.nih.gov/pubmed/29755674 http://dx.doi.org/10.18632/oncotarget.25020 |
Ejemplares similares
-
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023) -
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society
por: Baron, Frédéric, et al.
Publicado: (2015) -
MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
por: Lechanteur, Chantal, et al.
Publicado: (2021) -
Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
por: Lechanteur, Chantal, et al.
Publicado: (2016) -
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
por: Vandenhove, Benoît, et al.
Publicado: (2020)